Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Director/Managing Director/Vice Chairman of the Board
64 yrs
FAQs
How to Buy Aurobindo Pharma Ltd Stock?
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Aurobindo Pharma Ltd or scroll over to Aurobindo Pharma Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Aurobindo Pharma Ltd?
The share price of Aurobindo Pharma Ltd stocks is ₹1,129.45 as on 12/05/2024
What is the Market Cap of Aurobindo Pharma Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Aurobindo Pharma Ltd stock is ₹66,178.8 Cr on 12/05/2024.
In which sector / industry does Aurobindo Pharma Ltd operate?
Aurobindo Pharma Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Aurobindo Pharma Ltd?
The revenue of Aurobindo Pharma Ltd as of 2022 was ₹24,617.1 Cr
What is the PE ratio of Aurobindo Pharma Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Aurobindo Pharma Ltd is
23.91 as on 12/05/2024.
What is the 52 week high price of Aurobindo Pharma Ltd?
The 52 week high of Aurobindo Pharma Ltd stock is ₹1,175.60.
What is the 52 week low price of Aurobindo Pharma Ltd?
The 52 week low of Aurobindo Pharma Ltd stock is ₹581.50.
Can fractional shares of Aurobindo Pharma Ltd be purchased?
No, you cannot buy fractional shares of Aurobindo Pharma Ltd, or any listed Indian company as of now.